DEXCOM INC (1DXCM.MI) Stock Fundamental Analysis
Europe - BIT:1DXCM - US2521311074 - Common Stock
55.51 EUR
-3.23 (-5.5%)
We assign a fundamental rating of 6 out of 10 to 1DXCM. 1DXCM was compared to 60 industry peers in the Health Care Equipment & Supplies industry. 1DXCM has an excellent profitability rating, but there are some minor concerns on its financial health. 1DXCM is valued quite expensively, but it does show have an excellent growth rating. These ratings would make 1DXCM suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year 1DXCM was profitable.
In the past year 1DXCM had a positive cash flow from operations.
In the past 5 years 1DXCM has always been profitable.
Each year in the past 5 years 1DXCM had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 7.80%, 1DXCM is in the better half of the industry, outperforming 79.37% of the companies in the same industry.
1DXCM has a better Return On Equity (22.21%) than 90.48% of its industry peers.
With an excellent Return On Invested Capital value of 14.52%, 1DXCM belongs to the best of the industry, outperforming 93.65% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for 1DXCM is above the industry average of 9.00%.
The 3 year average ROIC (11.25%) for 1DXCM is below the current ROIC(14.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROIC | 14.52% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
1.3 Margins
With a decent Profit Margin value of 13.29%, 1DXCM is doing good in the industry, outperforming 76.19% of the companies in the same industry.
In the last couple of years the Profit Margin of 1DXCM has grown nicely.
With a decent Operating Margin value of 17.22%, 1DXCM is doing good in the industry, outperforming 76.19% of the companies in the same industry.
1DXCM's Operating Margin has improved in the last couple of years.
1DXCM's Gross Margin of 60.01% is in line compared to the rest of the industry. 1DXCM outperforms 58.73% of its industry peers.
1DXCM's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% |
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1DXCM is creating value.
The number of shares outstanding for 1DXCM has been increased compared to 1 year ago.
1DXCM has more shares outstanding than it did 5 years ago.
The debt/assets ratio for 1DXCM has been reduced compared to a year ago.
2.2 Solvency
1DXCM has an Altman-Z score of 4.79. This indicates that 1DXCM is financially healthy and has little risk of bankruptcy at the moment.
1DXCM's Altman-Z score of 4.79 is amongst the best of the industry. 1DXCM outperforms 84.13% of its industry peers.
1DXCM has a debt to FCF ratio of 4.38. This is a neutral value as 1DXCM would need 4.38 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.38, 1DXCM is doing good in the industry, outperforming 63.49% of the companies in the same industry.
A Debt/Equity ratio of 0.50 indicates that 1DXCM is somewhat dependend on debt financing.
1DXCM has a Debt to Equity ratio (0.50) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Altman-Z | 4.79 |
ROIC/WACC1.84
WACC7.9%
2.3 Liquidity
1DXCM has a Current Ratio of 1.52. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
1DXCM has a Current ratio of 1.52. This is comparable to the rest of the industry: 1DXCM outperforms 42.86% of its industry peers.
1DXCM has a Quick Ratio of 1.35. This is a normal value and indicates that 1DXCM is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.35, 1DXCM is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
The earnings per share for 1DXCM have decreased by -2.86% in the last year.
Measured over the past years, 1DXCM shows a very strong growth in Earnings Per Share. The EPS has been growing by 29.25% on average per year.
1DXCM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.30%.
1DXCM shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 22.27% yearly.
EPS 1Y (TTM)-2.86%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%11.63%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%15.21%
3.2 Future
The Earnings Per Share is expected to grow by 22.60% on average over the next years. This is a very strong growth
Based on estimates for the next years, 1DXCM will show a quite strong growth in Revenue. The Revenue will grow by 13.90% on average per year.
EPS Next Y26.84%
EPS Next 2Y26.2%
EPS Next 3Y24.65%
EPS Next 5Y22.6%
Revenue Next Year14.99%
Revenue Next 2Y15.17%
Revenue Next 3Y14.81%
Revenue Next 5Y13.9%
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 38.28 indicates a quite expensive valuation of 1DXCM.
Compared to the rest of the industry, the Price/Earnings ratio of 1DXCM is on the same level as its industry peers.
When comparing the Price/Earnings ratio of 1DXCM to the average of the S&P500 Index (27.86), we can say 1DXCM is valued slightly more expensively.
With a Price/Forward Earnings ratio of 24.79, 1DXCM is valued on the expensive side.
1DXCM's Price/Forward Earnings is on the same level as the industry average.
1DXCM's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.32.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.28 | ||
| Fwd PE | 24.79 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1DXCM is valued a bit more expensive than 60.32% of the companies in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as 1DXCM.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.75 | ||
| EV/EBITDA | 23.9 |
4.3 Compensation for Growth
1DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
1DXCM has an outstanding profitability rating, which may justify a higher PE ratio.
1DXCM's earnings are expected to grow with 24.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.43
PEG (5Y)1.31
EPS Next 2Y26.2%
EPS Next 3Y24.65%
5. Dividend
5.1 Amount
No dividends for 1DXCM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1DXCM (10/2/2025, 7:00:00 PM)
55.51
-3.23 (-5.5%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners97.73%
Inst Owner ChangeN/A
Ins Owners0.19%
Ins Owner ChangeN/A
Market Cap21.77B
Analysts84.57
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.34%
Min EPS beat(2)-4.09%
Max EPS beat(2)6.77%
EPS beat(4)2
Avg EPS beat(4)-1.87%
Min EPS beat(4)-11.66%
Max EPS beat(4)6.77%
EPS beat(8)6
Avg EPS beat(8)9.43%
EPS beat(12)10
Avg EPS beat(12)14.38%
EPS beat(16)11
Avg EPS beat(16)8.49%
Revenue beat(2)1
Avg Revenue beat(2)0.34%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)0.88%
Revenue beat(4)1
Avg Revenue beat(4)-0.54%
Min Revenue beat(4)-1.66%
Max Revenue beat(4)0.88%
Revenue beat(8)2
Avg Revenue beat(8)-0.78%
Revenue beat(12)5
Avg Revenue beat(12)-0.39%
Revenue beat(16)6
Avg Revenue beat(16)-0.42%
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0.31%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)1.25%
EPS NY rev (3m)1.25%
Revenue NQ rev (1m)0.75%
Revenue NQ rev (3m)0.75%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 38.28 | ||
| Fwd PE | 24.79 | ||
| P/S | 5.94 | ||
| P/FCF | 44.75 | ||
| P/OCF | 25.86 | ||
| P/B | 9.93 | ||
| P/tB | 10.38 | ||
| EV/EBITDA | 23.9 |
EPS(TTM)1.45
EY2.61%
EPS(NY)2.24
Fwd EY4.03%
FCF(TTM)1.24
FCFY2.23%
OCF(TTM)2.15
OCFY3.87%
SpS9.35
BVpS5.59
TBVpS5.35
PEG (NY)1.43
PEG (5Y)1.31
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.8% | ||
| ROE | 22.21% | ||
| ROCE | 18.43% | ||
| ROIC | 14.52% | ||
| ROICexc | 53.56% | ||
| ROICexgc | 59.66% | ||
| OM | 17.22% | ||
| PM (TTM) | 13.29% | ||
| GM | 60.01% | ||
| FCFM | 13.27% |
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
ROICexc(3y)35.45%
ROICexc(5y)29.66%
ROICexgc(3y)40.94%
ROICexgc(5y)33.19%
ROCE(3y)14.28%
ROCE(5y)11.73%
ROICexcg growth 3Y55.18%
ROICexcg growth 5Y18.96%
ROICexc growth 3Y50.14%
ROICexc growth 5Y16.58%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
F-Score6
Asset Turnover0.59
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.5 | ||
| Debt/FCF | 4.38 | ||
| Debt/EBITDA | 1.33 | ||
| Cap/Depr | 176.58% | ||
| Cap/Sales | 9.69% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.12% | ||
| Profit Quality | 99.88% | ||
| Current Ratio | 1.52 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 4.79 |
F-Score6
WACC7.9%
ROIC/WACC1.84
Cap/Depr(3y)175.34%
Cap/Depr(5y)240.83%
Cap/Sales(3y)9.32%
Cap/Sales(5y)10.84%
Profit Quality(3y)97.76%
Profit Quality(5y)73.64%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.86%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%11.63%
EPS Next Y26.84%
EPS Next 2Y26.2%
EPS Next 3Y24.65%
EPS Next 5Y22.6%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%15.21%
Revenue Next Year14.99%
Revenue Next 2Y15.17%
Revenue Next 3Y14.81%
Revenue Next 5Y13.9%
EBIT growth 1Y6.1%
EBIT growth 3Y30.52%
EBIT growth 5Y33.11%
EBIT Next Year77.25%
EBIT Next 3Y38.83%
EBIT Next 5Y31.4%
FCF growth 1Y22.49%
FCF growth 3Y127.88%
FCF growth 5Y36.21%
OCF growth 1Y28.04%
OCF growth 3Y30.77%
OCF growth 5Y25.76%